Outcome of Frontline Treatment with “Generic” Imatinib In Adult Patients with Chronic Myeloid Leukemia in Algerian Population: A Multicenter Study

INTRODUCTION: In a developing country like Algeria, such expensive therapy is not available. Alternative approaches are needed to help these adult. In Algeria ‘imatib’ (CIPLA-India) was introduced in 2006; but no study has been published yet in the North Africa region regarding response and outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Entasoltan, B., Bekadja, M.A., Touhami, H., Mehalhal, N., Zouaoui, Z., Mesli, N., Talbi, M., Bachiri, A., Michallet, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667527/
https://www.ncbi.nlm.nih.gov/pubmed/29181139
http://dx.doi.org/10.4084/MJHID.2017.062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667527/
https://www.ncbi.nlm.nih.gov/pubmed/29181139
http://dx.doi.org/10.4084/MJHID.2017.062

Ejemplares similares